NorthwestPharmacy.SU - Your Online Medical Resource - Page 2

Benzodiazepine Tapering: Safe Strategies to Reduce Dependence
11 March 2026

Benzodiazepine Tapering: Safe Strategies to Reduce Dependence

Benzodiazepine tapering is a safe, evidence-based way to reduce dependence on medications like Xanax and Valium. Learn the science-backed steps, timelines, and support strategies that help people successfully stop without severe withdrawal.

Read More
Cancer Medication Combinations: Bioequivalence Challenges for Generics
7 March 2026

Cancer Medication Combinations: Bioequivalence Challenges for Generics

by Prasham Sheth 14 Comments

Cancer combination therapies rely on precise drug interactions - but generic versions may disrupt this balance. Learn why bioequivalence standards fail for multi-drug regimens and what patients and providers need to know.

Read More
Pharmacist Recommendations: When to Suggest Authorized Generics
4 March 2026

Pharmacist Recommendations: When to Suggest Authorized Generics

by Prasham Sheth 12 Comments

Pharmacists should recommend authorized generics for patients with allergies to inactive ingredients, those on narrow therapeutic index drugs, or when consistency matters. They're identical to brand-name drugs but often cheaper-though insurance coverage can vary.

Read More
FDA Warning Letters: What Manufacturers Must Know About CGMP Violations
28 February 2026

FDA Warning Letters: What Manufacturers Must Know About CGMP Violations

by Prasham Sheth 15 Comments

FDA warning letters are serious enforcement actions against drug manufacturers for CGMP violations. Learn what triggers them, how they impact businesses, and how companies can respond effectively to avoid costly delays and regulatory escalation.

Read More
FDA Warning Letters: What Manufacturers Must Know About CGMP Violations
28 February 2026

FDA Warning Letters: What Manufacturers Must Know About CGMP Violations

by Prasham Sheth 14 Comments

FDA warning letters are formal notices to drug manufacturers for violating quality standards. They cite specific regulatory failures, demand corrective actions, and are publicly posted. Learn what triggers them, how to respond, and why they’re costing companies millions.

Read More
Diabetes and Heart Disease: How Medications and Lifestyle Work Together to Reduce Risk
27 February 2026

Diabetes and Heart Disease: How Medications and Lifestyle Work Together to Reduce Risk

Diabetes greatly increases heart disease risk, but combining GLP-1 receptor agonists like semaglutide with proven lifestyle changes can slash cardiovascular events by over 60%. Learn how medication and habits work together to protect your heart.

Read More
Psoriasis and Beta-Blockers: What You Need to Know About Skin Flare Risk
25 February 2026

Psoriasis and Beta-Blockers: What You Need to Know About Skin Flare Risk

Beta-blockers like metoprolol and propranolol can trigger or worsen psoriasis in about 20% of users. Learn how these common heart meds affect skin health-and what to do if your psoriasis flares after starting one.

Read More
OTC Cold Medications and Warfarin: What You Must Avoid to Prevent Dangerous Bleeding
21 February 2026

OTC Cold Medications and Warfarin: What You Must Avoid to Prevent Dangerous Bleeding

by Prasham Sheth 12 Comments

Warfarin users must avoid common OTC cold medicines like NSAIDs and high-dose acetaminophen to prevent dangerous bleeding. Learn which ingredients are safe, what to avoid, and how to stay protected during cold season.

Read More
Immunodeficiency Red Flags: Recurrent Infections and Workup
20 February 2026

Immunodeficiency Red Flags: Recurrent Infections and Workup

by Prasham Sheth 10 Comments

Recurrent infections can signal a hidden immune disorder. Learn the red flags, key diagnostic tests, and what to ask your doctor to catch immunodeficiency early-before it causes lasting harm.

Read More
When Pharmacists Should Flag Problematic Generic Drugs
18 February 2026

When Pharmacists Should Flag Problematic Generic Drugs

by Prasham Sheth 10 Comments

Pharmacists play a critical role in spotting problematic generics that can cause therapeutic failure or harm. Learn when to flag issues with NTI drugs, look-alike names, and inconsistent formulations - and how to protect patients.

Read More
1 2 3 4 5 21